Partnered Infographic

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Hematological oncology is a growing area of the global pharmaceutical pipeline, meaning more treatments in research and development are set to reach Phase I and II clinical studies.

With delays currently facing drug developers due to some contract manufacturing organizations (CMOs) experiencing backlogs, future expectations for these service providers are being redefined.